The GLP1R Agonist Liraglutide Reduces Hyperglucagonemia Induced by the SGLT2 Inhibitor Dapagliflozin via Somatostatin Release
about
The GLP1R Agonist Liraglutide Reduces Hyperglucagonemia Induced by the SGLT2 Inhibitor Dapagliflozin via Somatostatin Release
description
scientific article published on 01 August 2019
@en
name
The GLP1R Agonist Liraglutide ...... lozin via Somatostatin Release
@en
type
label
The GLP1R Agonist Liraglutide ...... lozin via Somatostatin Release
@en
prefLabel
The GLP1R Agonist Liraglutide ...... lozin via Somatostatin Release
@en
P2093
P50
P1433
P1476
The GLP1R Agonist Liraglutide ...... lozin via Somatostatin Release
@en
P2093
Anais Coddeville
Audrey Quenon
Corinne Bousquet
Ericka Moerman
François Pattou
Gianni Pasquetti
Julie Kerr-Conte
Marie-Christine Vantyghem
Mehdi Daoudi
Nathalie Delalleau
P304
1447-1454.e4
P356
10.1016/J.CELREP.2019.07.009
P577
2019-08-01T00:00:00Z